reSee.it - Related Video Feed

Vaccines are crucial and new ones are being developed. Some people spread misinformation about vaccines, but it's most prevalent in the United States. In the next five years, we can expect advancements in vaccines for tuberculosis, malaria, and HIV. Proteins play a vital role in this. The speaker acknowledges their high greenhouse gas footprint but emphasizes the importance of vaccines. They mention a significant investment in vaccinations and the need to prepare for future pandemics. Normalcy will gradually return after widespread vaccination, but some restrictions may remain for about nine months. The speaker believes we should learn from this pandemic and give attention to future threats.

Vaccines are crucial for public health. There will be new vaccines developed, including for TB, malaria, and HIV. Misinformation about vaccines is a problem, especially in the US. We need to invest in vaccinations, as it has a significant return on investment. Life will not fully return to normal until the global population is vaccinated. We must prepare for future pandemics.

The speaker discusses the world's population and the potential to lower it through vaccines and healthcare. They mention the use of lipid nanoparticles to create factories for vaccine production. The importance of vaccines is emphasized, especially for diseases without a vaccine. The speaker acknowledges the issue of vaccine hesitancy, particularly in developing countries, and the misinformation surrounding vaccines. They mention the tragedy of millions of deaths and the need to move on. The conversation concludes with a mention of preparing for the future and rejecting the idea that vaccines cause harm.

"There's the transformative, if I might use that word, experience that we've all had now in year five of COVID." The speaker says, "The thought that we won't have another pandemic, I think is naive at best and just not completely unrealistic at worst." They add, "I'm convinced that there will be another pandemic and that's the reason why we have to be perpetually prepared to prevent the terrible impact of a pandemic."

The world's perception of influenza needs to change in order to address the problem effectively. There is a possibility of a novel avian virus outbreak in China, which could have devastating consequences. If another pandemic were to occur, millions of people could die within a short period of time. Disruptive and iterative approaches are necessary to tackle this issue. The government has a role to play in pushing the industry to prioritize public health over profit. The perception of influenza is not as serious as other diseases, which makes it difficult to bring about change. Resources need to be allocated more efficiently during crises, and synthetic-based vaccines could revolutionize the field. The goal is to align different capabilities, funding streams, and incentives towards a common goal. More resources and financial incentives could attract new talent to the field.

The speaker discusses the devastating impact of the deaths caused by the current situation. They anticipate that this will shift the focus of research and development budgets towards addressing the lack of vaccines that can effectively block transmission. While current vaccines help improve individual health, they only offer limited reduction in transmission. The speaker emphasizes the need for a new approach to vaccine development.

The speakers discuss the need for a new and improved method of vaccine production. They acknowledge the challenges of transitioning from the current egg-growing process to a more efficient method. The process of proving the effectiveness of a new vaccine and going through clinical trials can take up to a decade. They suggest the need for a disruptive entity that is not bound by bureaucratic processes to address the problem of influenza. They also mention the possibility of using RNA sequences from novel avian viruses in China to create vaccines that can be self-administered through patches.

The speaker argues that people don’t feel like going to the stadium due to infection risk and that you don’t have a choice; it’s not the government telling them to ignore the disease. People are deeply affected by seeing these deaths and by knowing they could be part of the transmission chain, with old people, their parents, and grandparents potentially affected. There will be the ability, particularly in rich countries, to open up if things are done well over the next few months. But for the world at large, normalcy only returns when we've largely vaccinated the entire global population.

Speaker 0 discusses the development, adoption, and scaling of vaccines for different variants and subvariants. They highlight the concern surrounding this issue and the context of the discussion. Speaker 1 shares the good news that there is now manufacturing capacity for vaccines. They recall a conversation where they expressed the need to produce a billion vaccines in the following year due to the pandemic.

The speakers discuss the expected mutation of the virus and the impact of vaccination. They acknowledge that as people become immunized, the virus will try to find ways to evade the vaccine. The more people are vaccinated, the more pressure is put on the virus to mutate. Some virologists warn that vaccinating the entire world with narrow immunity could lead to the emergence of superbugs. They urge for the use of the right vaccine in the right place and caution against mass vaccination during a pandemic. They argue that current interventions and mass vaccination may be causing more harm than good, driving the emergence of more infectious and potentially lethal variants.

The speaker discusses the devastating impact of the deaths caused by the current situation. They predict that this will lead to a shift in research and development budgets towards addressing the lack of vaccines that can effectively block transmission. While current vaccines help with individual health, they only offer limited reduction in transmission. The speaker emphasizes the need for a new approach to vaccine development.

The situation has been horrific, leading to a shift in research and development budgets. Current vaccines primarily focus on improving individual health but only slightly reduce transmission. There is a need for a new approach to vaccine development that effectively blocks transmission.

The speaker discusses the evolution of the COVID-19 pandemic from an acute phase to a chronic phase. They explain that the suboptimal immune response caused by vaccination is leading to immune escape and immune pathology. The virus is continuing to evolve and will eventually overcome the suboptimal forces, leaving no immune resistance in the vaccinated population. The unvaccinated population, on the other hand, has been able to train their immune system and still has immune defense. The speaker emphasizes the importance of antiviral treatments like ivermectin in preventing reinfections and recommends taking them prophylactically. They predict a hyperacute phase of the disease and believe that the current public health authorities will be held accountable for their actions.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

The speaker discusses the devastating impact of the deaths caused by the current situation. They anticipate that this will shift the focus of research and development budgets towards addressing the lack of vaccines that can effectively block transmission. While current vaccines offer some health benefits, they only provide limited reduction in transmission. The speaker emphasizes the need for a new approach to vaccine development.

In this video, the speaker discusses potential causes of a significant increase in deaths, such as a large-scale war or a natural or bioterror pandemic. They express concern about the possibility of bioterrorism, as even a small terrorist group could cause widespread harm using nonhuman to human transmissible agents. The speaker also mentions the importance of global health security and how governments need to be prepared to allocate resources and make decisions during epidemics.

Due to budget constraints and a $30 billion cut in global health aid this year, progress is at risk and low-income countries will experience setbacks. Without sufficient resources for primary healthcare systems and vaccines, easily preventable diseases will continue to cause fatalities. The speaker highlighted the impact of resource cuts, emphasizing that a $0.30 vaccine could save a child's life. Although trend lines will reverse, the speaker believes that progress will resume with restored resources and innovations in drugs and vaccines. The timeline for recovery is uncertain, but the speaker is confident that advancements will continue.

The speaker discusses the devastating impact of the deaths caused by the current situation. They predict that this will result in a shift in research and development budgets towards addressing the lack of vaccines that can effectively block transmission. While current vaccines help improve individual health, they only offer limited reduction in transmission. The speaker emphasizes the need for a new approach to vaccine development.

The first speaker states that the entire mRNA platform and manufacturing process will be maintained for all future mRNA vaccines, and there is no attempt to change the technology or address problems with lipid nanoparticles—the same platform will be used in all future vaccines. The second speaker comments that the situation is not a failure but a population-level shift, noting, “Notice that children are men,” and adds that in this utopia, “oh, it doesn't kill you.” They claim it was weakened when the higher kill rate was observed because it was too strong, suggesting it was really targeted at long-term cancers, getting rid of old people, and sterilizing the young. The first speaker agrees, suggesting a depopulation plan that is long-term, with deaths not immediately visible to the public. They reference a quote from Dune: “The slow blade passes the shield.” The second speaker reiterates that line, and the first speaker concludes, “So this is a long term plan.”

The speaker discusses the devastating impact of the deaths caused by the current situation. They anticipate that this will shift the focus of research and development budgets towards addressing the lack of vaccines that can effectively block transmission. While current vaccines help improve individual health, they only offer limited reduction in transmission. Therefore, the speaker emphasizes the need for a new approach to vaccine development.

Worldwide, the death toll from the COVID vaccine is estimated to be over 13 million, possibly even 17 million. The speaker agrees with this estimate. They praise an interview with Brett Weinstein and agree with his points. The conversation then shifts to questioning how governments can ignore the deaths of over 10 million people and not take responsibility or make amends. This raises philosophical questions about accountability and morality.

“And we will have new vaccines. We'll have a, TB vaccine, malaria vaccine, HIV vaccine, and even the things like COVID vaccines.” The speaker envisions vaccines for TB, malaria, HIV, and COVID, with longer duration and broader coverage. “We need to make them have longer duration, more coverage, and we're gonna change instead of using the needle to use a little patch.” The plan includes longer-lasting protection and a switch from needle injections to patch delivery. “So the pandemic really highlighted that we've been underinvested in those innovations, and, you know, our partners in India are are part of how we're gonna get these breakthrough products done.” The pandemic is cited as underscoring underinvestment, with India-based partners playing a role in bringing breakthrough products to fruition.

The speaker believes mRNA shots are a "festering wound" impacting everyone that cannot be ignored. The speaker urges the new administration to address the issue, citing 500 mRNA shots in the pipeline, 33 of which are self-amplifying. Self-amplifying means they are designed to replicate indefinitely, which the speaker finds "terrifying" because current mRNA shots already lack an "off switch." The speaker claims these self-amplifying shots are already in use in Japan, India, and the EU. The speaker believes the one in the US pipeline is for H1N1, so it may not be used unless there is an issue, but they are still experimenting with it.

The speaker discusses the increase in COVID-19 cases and deaths after mass vaccination. They claim that the vaccines have created new variants of the virus and that the antibodies produced by the vaccines actually make the infection stronger. They argue that the new variants are a result of the selection of antibodies through vaccination. The speaker questions the decision to vaccinate during an ongoing epidemic and suggests that there are alternative treatments available.

New vaccines for tuberculosis, malaria, HIV, and COVID-19 are being developed. These vaccines aim to have longer-lasting effects and wider coverage. In addition, instead of using needles, a patch will be used for administration. The COVID-19 pandemic has brought attention to the fact that we have not invested enough in these innovative advancements.